发明授权
US09593129B2 Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
有权
哌啶酮衍生物作为治疗癌症的MDM2抑制剂
- 专利标题： Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
- 专利标题（中）： 哌啶酮衍生物作为治疗癌症的MDM2抑制剂
-
申请号： US15008342申请日： 2016-01-27
-
公开(公告)号： US09593129B2公开(公告)日： 2017-03-14
- 发明人: Michael D. Bartberger , Ana Gonzalez Buenrostro , Hilary Plake Beck , Xiaoqi Chen , Richard Victor Connors , Jeffrey Deignan , Jason A. Duquette , John Eksterowicz , Benjamin Fisher , Brian M. Fox , Jiasheng Fu , Zice Fu , Felix Gonzalez Lopez De Turiso , Michael W. Gribble, Jr. , Darin J. Gustin , Julie A. Heath , Xin Huang , XianYun Jiao , Michael G. Johnson , Frank Kayser , David John Kopecky , SuJen Lai , Yihong Li , Zhihong Li , Jiwen Liu , Jonathan D. Low , Brian S. Lucas , Zhihua Ma , Lawrence R. McGee , Joel McIntosh , Dustin L. McMinn , Julio C. Medina , Jeffrey Thomas Mihalic , Steven H. Olson , Yosup Rew , Philip M. Roveto , Daqing Sun , Xiaodong Wang , Yingcai Wang , Xuelei Yan , Ming Yu , Jiang Zhu
- 申请人： AMGEN INC.
- 申请人地址： US CA Thousand Oaks
- 专利权人： Amgen, Inc.
- 当前专利权人： Amgen, Inc.
- 当前专利权人地址： US CA Thousand Oaks
- 代理商 Markus Bergauer
- 主分类号： C07D498/14
- IPC分类号： C07D498/14 ; C07D221/20 ; C07D471/10 ; C07D211/76 ; C07D279/02 ; C07D401/04 ; C07D401/06 ; C07D401/12 ; C07D407/04 ; C07D407/06 ; C07D409/04 ; C07D413/06 ; C07D417/06 ; C07D498/08 ; C07D498/20 ; C07D405/04 ; C07D417/12 ; C07D417/14 ; C07D491/08 ; C07D491/153
摘要：
The present invention provides MDM2 inhibitor compounds of Formula I, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
公开/授权文献
信息查询
